Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance ...Middle East

PR Newswire - Economy
Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance
In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome ZUG, Switzerland, April 14, 2022 /PRNewswire/ -- Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of...

Hence then, the article about micreos pharmaceuticals announces success of its xz 700 technology in selectively eliminating staphylococcus aureus pathogen without triggering resistance was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance )

Apple Storegoogle play

Last updated :

Also on site :



Latest News